查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
dPCR 和 qPCR 市場規模和預測、全球和地區佔有率、趨勢以及按治療、產品、應用、最終用戶和地理位置進行的成長機會分析
市場調查報告書
商品編碼
1389606

dPCR 和 qPCR 市場規模和預測、全球和地區佔有率、趨勢以及按治療、產品、應用、最終用戶和地理位置進行的成長機會分析

dPCR and qPCR Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment, Product, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 159 Pages | 訂單完成後即時交付

價格

dPCR和qPCR市場規模預計將從2022年的89.76億美元成長到2030年的182.30億美元；預計2022-2030年CAGR為9.3%。

dPCR 和 qPCR 市場的成長歸因於遺傳性疾病和傳染病發病率的增加、基因合成投資和資金的增加以及 PCR 技術的技術進步。

近年來，PCR 等分子方法已發展成為診斷技術。此方法使醫療保健專業人員能夠準確診斷多種傳染病，被認為是不可或缺的研究和診斷工具。 PCR 允許從一條 DNA 鏈產生數百萬個 DNA 拷貝。它還可以實現疾病的早期診斷，因此在疾病控制中發揮重要作用。 PCR 可提供不同實驗室之間具有可比性的可重複結果，因此在全世界範圍內得到認可。隨著PCR技術在新興國家被廣泛接受和使用。根據世界衛生組織2016年關於在發展中國家建立PCR實驗室的報告，世衛組織正在提供必要的技術援助，以便在世衛組織東南亞國家的所有11個成員國建立PCR實驗室。這些實驗室將有助於提供高品質的醫療服務。這些PCR實驗室根據需要採用了不同的PCR技術，例如逆轉錄酶PCR（RT-PCR）、多重PCR、即時PCR、原位PCR、數位PCR（dPCR）等。由於其簡單、快速和高度特異性的疾病篩檢及其在臨床微生物學、病毒學、寄生蟲學、生物技術和相關領域的日益成長的應用，預計發展中國家的dPCR 和qPCR 市場將在預測期內經歷利潤豐厚的機會。

微滴式數位 PCR (ddPCR) 是一種進行數位 PCR 的新技術。它採用水油乳化液滴技術。待測樣品被分成約20,000個液滴，然後在每個液滴中進行目標DNA鏈的擴增。然後 ddPCR 以數位方式測量單一液滴中的核酸目標。因此，該技術可以對目標 DNA 分子進行高精度和絕對定量，並在診斷和研究中廣泛應用。在 qPCR 中，DNA 定量是根據循環閾值 (CT) 獲得的。需要外部校準器，且不完美的擴增會影響絕對定量。微滴式數位 PCR (ddPCR) 直接對目標 DNA 進行計數，無需校準曲線。因此，隨著 ddPCR 的出現，科學家將能夠探索複雜的遺傳景觀，發現和驗證新的疾病關聯，並定義分子診斷的新時代。因此，ddPCR的發展將成為未來dPCR和qPCR市場的一大趨勢。

基於應用程式的見解

根據應用，dPCR 和 qPCR 市場分為研究應用、臨床應用和法醫應用。 2022年，臨床應用領域佔最大市場佔有率，預計2022-2030年CAGR最高。分子生物學技術徹底改變了疾病診斷，現已成為實驗室診斷的重要組成部分。 dPCR 和 qPCR 技術現已用於許多疾病的診斷，包括糖尿病、傳染病、癌症等。例如，即時PCR技術RIDA GENE試劑盒是為診斷胃腸道感染、院內感染(HAI)、呼吸道感染、性傳染感染和其他參數而開發的。由於這些分子方法可以進行早期、敏感和特異性的診斷，因此臨床應用領域預計將在預測期內出現成長。

即時PCR技術已被用來檢測基因突變，這有助於癌症的診斷。 dPCR 也能夠精確檢測痰、尿液、腦脊髓液、血漿等無細胞 DNA (cfDNA) 樣本中的腫瘤標記。 dPCR 在檢測野生型序列中的單核苷酸多態性方面更有效。例如，dPCR 通常用於檢測表皮生長因子受體 (EGFR)、KRAS 和 ESR1 的突變。

此外，技術進步為診斷和治療癌症提供了分子標記。 2023 年 4 月，賽默飛世爾科技為其 QuantStudio Dx 系列儀器推出了 37 種帶有 CE-IVD 標記的即時 PCR 檢測試劑盒，用於檢測多種傳染病。

基於最終用戶的見解

根據最終用戶，dPCR 和 qPCR 市場分為醫院和診斷中心、製藥和生物技術公司、研究實驗室和學術機構、法醫實驗室和臨床研究組織。 2022年，醫院和診斷中心細分市場佔據最大市場佔有率，預計2022-2030年CAGR最高。

醫院和診斷中心為 dPCR 和 qPCR 市場貢獻了重要的市場佔有率。醫院是病患在訓練有素的人員指導下尋求先進治療的主要中心。 dPCR 和 qPCR 具有高靈敏度和特異性等優點，可以早期且準確地檢測病原體，包括細菌、病毒和真菌。

此外，醫院為患者提供先進的診斷和治療選擇，以治療急性和慢性疾病，醫院和診斷中心對PCR技術的採用率要高得多，因為它們為醫療機構提供了專門的科學設備。此外，新興國家醫療保健基礎設施的持續擴張、傳染病的高發生率以及住院人數的不斷增加，催生了對快速、靈敏的診斷工具的需求。此外，對早期有效的疾病診斷和治療的需求不斷成長，用於診斷應用的dPCR 產品數量不斷增加，dPCR 在疾病診斷中提供的優勢（與其他PCR 技術相比），以及公眾對其益處的認知不斷增強這些用於臨床和疾病診斷的技術推動了市場的成長。

此外，診斷實驗室配備了精良的高科技設備，可輕鬆實現各種待測試樣品的工作流程和管理。例如，Thermo Fisher Scientific, Inc. 提供多種 PCR 變體，包括 QuantStudio 5、QuantStudio 6 Flex、QuantStudio 7、QuantStudio 12k、QuantStudio 3D 和 QuantStudio Absolute Q AutoRun dPCR Suite。同樣，Bio-Rad Laboratories, Inc.、Fluidigm Corporation、Eppendorf 和 A​​gilent Technologies, Inc. 等多家公司根據醫院和診斷中心的能力和要求向其提供 PCR 設備。

疾病管制與預防中心、醫學研究未來基金和世界衛生組織 (WHO) 是準備 dPCR 和 qPCR 市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：dPCR 與 qPCR 市場模式

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：dPCR 和 qPCR 市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的發生率增加
    • 基因合成的投資和資金不斷增加
    • PCR 技術的技術進步
  • 市場限制
    • PCR 系統的高成本
    • 與 qPCR 相關的技術限制
  • 市場機會
    • 新興國家擴大採用 PCR 方法
  • 未來的趨勢
    • 微滴式數位PCR的發展
  • 影響分析：

第 6 章：dPCR 和 qPCR 市場 - 全球市場分析

  • dPCR 和 qPCR 市場收入，2022 - 2030

第 7 章：全球 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按治療方式

  • 概述
  • 2022 年和 2030 年按治療方式分類的 dPCR 和 qPCR 市場收入佔有率 (%)
  • 定量PCR
  • 數位PCR

第 8 章：全球 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的 dPCR 和 qPCR 市場收入佔有率 (%)
  • 試劑及耗材
  • 儀器
  • 軟體與服務

第 9 章：全球 dPCR 和 qPCR 市場 - 收入和 2030 年預測 -按應用

  • 概述
  • 2022 年和 2030 年按應用分類的 dPCR 和 qPCR 市場收入佔有率 (%)
  • 研究應用
  • 臨床應用
  • 法醫應用

第 10 章：全球 dPCR 和 qPCR 市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年按最終用戶分類的 dPCR 和 qPCR 市場收入佔有率 (%)
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究實驗室和學術機構
  • 法醫實驗室
  • 臨床研究組織

第 11 章：dPCR 和 qPCR 市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：dPCR 和 qPCR 市場-產業格局

  • 概述
  • dPCR 和 qPCR 市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Genome Diagnostics Pvt Ltd

第 14 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPHE100000817

The dPCR and qPCR market size is expected to grow from US$ 8.976 billion in 2022 to US$ 18.230 billion by 2030; it is estimated to record a CAGR of 9.3% during 2022-2030.

The dPCR and qPCR market growth is attributed to the increasing incidence of genetic and infectious diseases, rising investments and funds for gene synthesis, and technological advancements in PCR technologies.

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. According to the World Health Organization Report on the Establishment of PCR Laboratory in Developing Countries 2016, WHO is providing necessary technical assistance to establish PCR laboratories in all 11 member states of the WHO South East Asia countries. The laboratories will help in providing high-quality medical care. These PCR laboratories have adopted different PCR technologies such as Reverse transcriptase PCR (RT-PCR), Multiplex PCR, Real-time PCR, In-situ PCR, Digital PCR (dPCR), and others depending on their need. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

Droplet Digital PCR (ddPCR) is a new technique for performing digital PCR. It utilizes water-oil emulsion droplet technology. A sample to be tested is fractionated into around 20,000 droplets, and then amplification of the target DNA strand is carried out in each droplet. The ddPCR then digitally measures the nucleic acid targets in the individual droplet. Thus, the technique gives high precision and absolute quantification of target DNA molecules and enables wide application in diagnosis and research. In qPCR, DNA quantification is obtained from the cycle threshold (CT). External calibrators are required, and imperfect amplification affects absolute quantitation. Droplet Digital PCR (ddPCR) directly counts the target DNA without the calibration curve. Thus, with the advent of ddPCR, scientists will be able to explore complex genetic landscapes, discover and validate new disease associations, and define a new era of molecular diagnostics. Thus, the development of ddPCR would become a major trend in the dPCR and qPCR market in the future.

Application-Based Insights

Based on application, the dPCR and qPCR market is segmented into research application, clinical application, and forensic application. In 2022, the clinical application segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030. Molecular biology techniques have revolutionized disease diagnosis and are now a crucial part of laboratory diagnostics. The dPCR and qPCR techniques are now being used in the diagnosis of many diseases, including diabetes, infectious diseases, cancer, and others. For instance, real-time PCR technology RIDA GENE kits are developed for the diagnosis of gastrointestinal infections, hospital-acquired infections (HAI), respiratory infections, sexually transmitted infections, and other parameters. As these molecular methods allow early, sensitive, and specific diagnosis, the clinical application segment is expected to witness growth over the forecast period.

Real-time PCR technologies have been used to detect mutation in genes, which helps in the diagnosis of cancer. dPCR also enables precise detection of tumor markers in cell-free DNA (cfDNA) samples like sputum, urine, cerebrospinal fluid, plasma, and others. dPCR is more effective in detecting single-nucleotide polymorphism among the wild-type sequences. For example, dPCR is commonly used to detect mutation in epidermal growth factor receptor (EGFR), KRAS, and ESR1.

Furthermore, technological advancements are offering molecular markers for diagnosing and treating cancer. In April 2023, Thermo Fisher Scientific introduced 37 CE-IVD-marked real-time PCR assay kits for its QuantStudio Dx series of instruments to detect numerous infectious diseases.

End User-Based Insights

Based on end user, the dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. In 2022, the hospitals and diagnostic centers segment held the largest share of the market and is anticipated to register the highest CAGR during 2022-2030.

Hospitals and diagnostic centers contribute a significant market share to the dPCR and qPCR market. Hospitals are the primary centers for a patient seeking highly advanced treatment under the guidance of much-trained personnel. dPCR and qPCR offer advantages such as high sensitivity and specificity, allowing early and accurate detection of pathogens, including bacteria, viruses, and fungi.

In addition, hospitals offer advanced diagnosis and treatment options for patients to treat acute and chronic conditions, and the adoption of PCR techniques is much higher in hospitals and diagnostic centers as they provide healthcare facilities with specialized scientific equipment. Moreover, the continued expansion of healthcare infrastructure across emerging countries, the high incidences of infectious diseases, and the growing number of hospital admissions has created a need for rapid and sensitive diagnostic tools. Additionally, growing demand for early and efficient disease diagnosis and treatment, the increasing number of dPCR product launches for diagnostic applications, the advantages offered by dPCR in disease diagnosis (as compared to other PCR technologies), and growing awareness among public associated with the benefits offered by both these technologies for clinical and disease diagnosis fuel the market growth.

Furthermore, diagnostic laboratories are well-equipped with hi-tech equipment that enables easy workflow and management of various samples to be tested. For instance, Thermo Fisher Scientific, Inc. offers multiple variants of its PCR, including QuantStudio 5, QuantStudio 6 Flex, QuantStudio 7, QuantStudio 12k, QuantStudio 3D, and QuantStudio Absolute Q AutoRun dPCR Suite. Similarly, several companies, such as Bio-Rad Laboratories, Inc., Fluidigm Corporation, Eppendorf, and Agilent Technologies, Inc., offer PCR devices to hospitals and diagnostic centers based on their capacity and requirements.

Centers for Disease Control and Prevention, Medical Research Future Fund, and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the dPCR and qPCR market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the dPCR and qPCR market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global dPCR and qPCR market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interests with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. dPCR and qPCR Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. dPCR and qPCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 5.1.2 Rising Investments and Funds for Gene Synthesis
    • 5.1.3 Technological Advancements in PCR Technologies
  • 5.2 Market Restraints
    • 5.2.1 High Costs of PCR Systems
    • 5.2.2 Technical Limitations Associated with qPCR
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Droplet Digital PCR
  • 5.5 Impact Analysis:

6. dPCR and qPCR Market - Global Market Analysis

  • 6.1 dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 7.1 Overview
  • 7.2 dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 7.3 Quantitative PCR
    • 7.3.1 Overview
    • 7.3.2 Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Digital PCR
    • 7.4.1 Overview
    • 7.4.2 Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 8.1 Overview
  • 8.2 dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 8.3 Reagents & Consumables
    • 8.3.1 Overview
    • 8.3.2 Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Instruments
    • 8.4.1 Overview
    • 8.4.2 Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Software & Services
    • 8.5.1 Overview
    • 8.5.2 Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Research Application
    • 9.3.1 Overview
    • 9.3.2 Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinical Application
    • 9.4.1 Overview
    • 9.4.2 Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 9.5 Forensic Application
    • 9.5.1 Overview
    • 9.5.2 Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. Global dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 10.1 Overview
  • 10.2 dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 10.3 Hospitals and Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical and Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research Laboratories and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Forensic Laboratories
    • 10.6.1 Overview
    • 10.6.2 Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.7 Clinical Research Organizations
    • 10.7.1 Overview
    • 10.7.2 Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. dPCR and qPCR Market - Geographical Analysis

  • 11.1 North America dPCR and qPCR Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.1.4 North America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.1.5 North America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.1.5.1 North America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.1.6 North America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.1 North America dPCR and qPCR Market, by Country
      • 11.1.6.2 US
        • 11.1.6.2.1 US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.2.2 US: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.2.3 US: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.2.4 US: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.2.4.1 US: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.2.5 US: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.3 Canada
        • 11.1.6.3.1 Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.3.2 Canada: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.3.3 Canada: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.3.4 Canada: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.3.4.1 Canada: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.3.5 Canada: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.1.6.4 Mexico
        • 11.1.6.4.1 Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.6.4.2 Mexico: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.1.6.4.3 Mexico: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.1.6.4.4 Mexico: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.1.6.4.4.1 Mexico: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.1.6.4.5 Mexico: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.2 Europe dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.2.4 Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.2.5 Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.2.5.1 Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.2.6 Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.1 Europe dPCR and qPCR Market, by Country
      • 11.2.6.2 UK
        • 11.2.6.2.1 UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.2.2 UK: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.2.3 UK: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.2.4 UK: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.2.4.1 UK: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.2.5 UK: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.3 Germany
        • 11.2.6.3.1 Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.3.2 Germany: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.3.3 Germany: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.3.4 Germany: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.3.4.1 Germany: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.3.5 Germany: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.4 France
        • 11.2.6.4.1 France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.4.2 France: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.4.3 France: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.4.4 France: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.4.4.1 France: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.4.5 France: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.5 Italy
        • 11.2.6.5.1 Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.5.2 Italy: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.5.3 Italy: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.5.4 Italy: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.5.4.1 Italy: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.5.5 Italy: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.6 Spain
        • 11.2.6.6.1 Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.6.2 Spain: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.6.3 Spain: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.6.4 Spain: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.6.4.1 Spain: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.6.5 Spain: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.2.6.7 Rest of Europe
        • 11.2.6.7.1 Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.6.7.2 Rest of Europe: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.2.6.7.3 Rest of Europe: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.2.6.7.4 Rest of Europe: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.2.6.7.4.1 Rest of Europe: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.2.6.7.5 Rest of Europe: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.3.5.1 Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.3.6 Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.1 Asia Pacific dPCR and qPCR Market, by Country
      • 11.3.6.2 China
        • 11.3.6.2.1 China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.2.2 China: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.2.3 China: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.2.4 China: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.2.4.1 China: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.2.5 China: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.3 Japan
        • 11.3.6.3.1 Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.3.2 Japan: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.3.3 Japan: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.3.4 Japan: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.3.4.1 Japan: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.3.5 Japan: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.4 India
        • 11.3.6.4.1 India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.4.2 India: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.4.3 India: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.4.4 India: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.4.4.1 India: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.4.5 India: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.5 Australia
        • 11.3.6.5.1 Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.5.2 Australia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.5.3 Australia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.5.4 Australia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.5.4.1 Australia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.5.5 Australia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.6 South Korea
        • 11.3.6.6.1 South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.6.2 South Korea: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.6.3 South Korea: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.6.4 South Korea: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.6.4.1 South Korea: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.6.5 South Korea: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.3.6.7 Rest of Asia Pacific
        • 11.3.6.7.1 Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.6.7.2 Rest of Asia Pacific: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.3.6.7.3 Rest of Asia Pacific: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.3.6.7.4 Rest of Asia Pacific: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.3.6.7.4.1 Rest of Asia Pacific: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.3.6.7.5 Rest of Asia Pacific: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.4.5.1 Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.4.6 Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.1 Middle East & Africa dPCR and qPCR Market, by Country
      • 11.4.6.2 Saudi Arabia
        • 11.4.6.2.1 Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.2.2 Saudi Arabia: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.2.3 Saudi Arabia: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.2.4 Saudi Arabia: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.2.4.1 Saudi Arabia: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.2.5 Saudi Arabia: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.3 UAE
        • 11.4.6.3.1 UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.3.2 UAE: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.3.3 UAE: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.3.4 UAE: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.3.4.1 UAE: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.3.5 UAE: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.4 South Africa
        • 11.4.6.4.1 South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.4.2 South Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.4.3 South Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.4.4 South Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.4.4.1 South Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.4.5 South Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.4.6.5 Rest of Middle East & Africa
        • 11.4.6.5.1 Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.6.5.2 Rest of Middle East & Africa: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.4.6.5.3 Rest of Middle East & Africa: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.4.6.5.4 Rest of Middle East & Africa: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.4.6.5.4.1 Rest of Middle East & Africa: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.4.6.5.5 Rest of Middle East & Africa: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
  • 11.5 South & Central America dPCR and qPCR Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
      • 11.5.5.1 South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
    • 11.5.6 South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.1 South & Central America dPCR and qPCR Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.2.3 Brazil: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.2.4 Brazil: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.2.4.1 Brazil: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.2.5 Brazil: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.3.3 Argentina: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.3.4 Argentina: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.3.4.1 Argentina: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.3.5 Argentina: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America: dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 11.5.6.4.3 Rest of South & Central America: dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 11.5.6.4.4 Rest of South & Central America: dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 11.5.6.4.4.1 Rest of South & Central America: dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 11.5.6.4.5 Rest of South & Central America: dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in dPCR and qPCR Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Thermo Fisher Scientific Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Takara Bio Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Qiagen NV
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Standard BioTools Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lepu Medical Technology Beijing Co Ltd
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 F. Hoffmann-La Roche Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Bio-Rad Laboratories Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Agilent Technologies Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Genome Diagnostics Pvt Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 SWOT Analysis
    • 13.10.5 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. dPCR and qPCR Market Segmentation
  • Table 2. dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. UK dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. UK dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. UK dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. UK dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Germany dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Germany dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Germany dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Germany dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Germany dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. France dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. France dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. France dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. France dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. France dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Italy dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Italy dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Italy dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Italy dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Italy dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Spain dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Spain dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Spain dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Spain dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Spain dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Rest of Europe dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Europe dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Europe dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Rest of Europe dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Rest of Europe dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. China dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. China dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. China dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. China dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. China dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Japan dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Japan dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Japan dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Japan dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Japan dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. India dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. India dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. India dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. India dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. India dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Australia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Australia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Australia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Australia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Australia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South Korea dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. South Korea dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. South Korea dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. South Korea dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. South Korea dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. Rest of Asia Pacific dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. Rest of Asia Pacific dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. Rest of Asia Pacific dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. Rest of Asia Pacific dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Asia Pacific dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Saudi Arabia dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Saudi Arabia dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Saudi Arabia dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Saudi Arabia dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Saudi Arabia dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. UAE dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. UAE dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. UAE dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. UAE dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. UAE dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. South Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. South Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. South Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. South Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. South Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Rest of Middle East & Africa dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Rest of Middle East & Africa dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Rest of Middle East & Africa dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Rest of Middle East & Africa dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Rest of Middle East & Africa dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Brazil dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. Brazil dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. Brazil dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. Brazil dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. Brazil dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. Argentina dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. Argentina dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. Argentina dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. Argentina dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. Argentina dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. Rest of South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. Rest of South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. Rest of South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Recent Organic Growth Strategies in dPCR and qPCR Market
  • Table 139. Recent Inorganic Growth Strategies in the dPCR and qPCR Market
  • Table 140. Glossary of Terms, dPCR and qPCR Market

List Of Figures

  • Figure 1. dPCR and qPCR Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. dPCR and qPCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. dPCR and qPCR Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 8. Quantitative PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Digital PCR: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 11. Reagents & Consumables: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Instruments: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Software & Services: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 15. Research Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Clinical Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Forensic Application: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 19. Hospitals and Diagnostic Centers: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Pharmaceutical and Biotechnology Companies: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Research Laboratories and Academic Institutes: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Forensic Laboratories: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Clinical Research Organizations: dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. China dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil dCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in dPCR and qPCR Market